hero image
Eliana, actual patient with Dravet syndrome, and Tatiana, her mother and caregiver

Celebrate Everyday Wins

DIACOMIT® (stiripentol) helps patients achieve profound seizure reduction so families can celebrate everyday wins.1,6

DIACOMIT is an FDA-approved antiseizure medication developed specifically to treat seizures associated with Dravet syndrome in children 6 months and older (weighing 15 lb or more) taking clobazam.

Make the DIACOMITment

Achieve Profound Seizure Reduction With DIACOMIT

We know that finding the right combination of antiseizure treatments for your child is critical. With DIACOMIT (stiripentol), profound seizure reduction is possible. Treatment can be initiated as early as 6 months.  Results may vary.

homepage infographic
icon
DIACOMIT Study Results

DIACOMIT is proven to significantly reduce generalized clonic or tonic clonic seizures. 1,6-8

Review the Research
icon
Starting on DIACOMIT

DIACOMIT is available in different forms and doses to fit your child’s unique needs.

Get Started
icon
Accessing DIACOMIT

Biocodex is By Your Side, making it easier than ever to fill a prescription for DIACOMIT.

Find Support
img banner Julia, age 7, actual patient on DIACOMIT

Living with Dravet Syndrome

A Dravet syndrome diagnosis is life-changing, and there are resources and communities available to help.

Learn More

IMPORTANT SAFETY INFORMATION

WARNINGS & PRECAUTIONS

SleepinessDIACOMIT can cause sleepiness. Your healthcare provider should monitor you for sleepiness, particularly when DIACOMIT is used with other depressants or clobazam.

Decreased Appetite and WeightDIACOMIT can cause a loss in appetite and weight. Your healthcare provider should monitor your growth and weight carefully.

Read All